nodes	percent_of_prediction	percent_of_DWPC	metapath
Guanfacine—CYP2C19—Thalidomide—leprosy	0.151	0.169	CbGbCtD
Guanfacine—CYP2C19—Rifampicin—leprosy	0.146	0.163	CbGbCtD
Guanfacine—CYP2C9—Thalidomide—leprosy	0.126	0.14	CbGbCtD
Guanfacine—CYP2C9—Rifampicin—leprosy	0.122	0.136	CbGbCtD
Guanfacine—CYP2C19—Dapsone—leprosy	0.121	0.135	CbGbCtD
Guanfacine—CYP2C9—Dapsone—leprosy	0.1	0.112	CbGbCtD
Guanfacine—CYP3A4—Rifampicin—leprosy	0.0707	0.079	CbGbCtD
Guanfacine—CYP3A4—Dapsone—leprosy	0.0584	0.0652	CbGbCtD
Guanfacine—NISCH—Menadione—Thalidomide—leprosy	0.00855	1	CbGdCrCtD
Guanfacine—Enuresis—Thalidomide—leprosy	0.0069	0.0715	CcSEcCtD
Guanfacine—Skin exfoliation—Dapsone—leprosy	0.00368	0.0381	CcSEcCtD
Guanfacine—Atrioventricular block—Thalidomide—leprosy	0.00203	0.0211	CcSEcCtD
Guanfacine—Skin exfoliation—Thalidomide—leprosy	0.00188	0.0195	CcSEcCtD
Guanfacine—Cramps of lower extremities—Thalidomide—leprosy	0.00181	0.0188	CcSEcCtD
Guanfacine—Tinnitus—Dapsone—leprosy	0.0018	0.0187	CcSEcCtD
Guanfacine—Vascular purpura—Thalidomide—leprosy	0.0016	0.0166	CcSEcCtD
Guanfacine—Vision blurred—Dapsone—leprosy	0.00159	0.0165	CcSEcCtD
Guanfacine—Cardiac failure congestive—Thalidomide—leprosy	0.00158	0.0164	CcSEcCtD
Guanfacine—Renal failure acute—Thalidomide—leprosy	0.00155	0.0161	CcSEcCtD
Guanfacine—Amnesia—Thalidomide—leprosy	0.00152	0.0158	CcSEcCtD
Guanfacine—Dermatitis exfoliative—Thalidomide—leprosy	0.00152	0.0157	CcSEcCtD
Guanfacine—Vertigo—Dapsone—leprosy	0.00151	0.0157	CcSEcCtD
Guanfacine—Purpura—Thalidomide—leprosy	0.00149	0.0154	CcSEcCtD
Guanfacine—Lethargy—Thalidomide—leprosy	0.00146	0.0151	CcSEcCtD
Guanfacine—Cerebrovascular accident—Thalidomide—leprosy	0.00146	0.0151	CcSEcCtD
Guanfacine—Pain in extremity—Thalidomide—leprosy	0.00143	0.0148	CcSEcCtD
Guanfacine—Affect lability—Thalidomide—leprosy	0.00141	0.0146	CcSEcCtD
Guanfacine—Tachycardia—Dapsone—leprosy	0.00134	0.0139	CcSEcCtD
Guanfacine—Liver function test abnormal—Thalidomide—leprosy	0.00132	0.0137	CcSEcCtD
Guanfacine—Orthostatic hypotension—Thalidomide—leprosy	0.00131	0.0136	CcSEcCtD
Guanfacine—Alanine aminotransferase increased—Thalidomide—leprosy	0.00126	0.0131	CcSEcCtD
Guanfacine—Insomnia—Dapsone—leprosy	0.00124	0.0129	CcSEcCtD
Guanfacine—Dysphagia—Thalidomide—leprosy	0.00124	0.0128	CcSEcCtD
Guanfacine—Pollakiuria—Thalidomide—leprosy	0.00114	0.0118	CcSEcCtD
Guanfacine—Erectile dysfunction—Thalidomide—leprosy	0.00114	0.0118	CcSEcCtD
Guanfacine—Weight increased—Thalidomide—leprosy	0.00113	0.0117	CcSEcCtD
Guanfacine—Gastrointestinal pain—Dapsone—leprosy	0.00112	0.0117	CcSEcCtD
Guanfacine—Drowsiness—Thalidomide—leprosy	0.0011	0.0114	CcSEcCtD
Guanfacine—Acute coronary syndrome—Thalidomide—leprosy	0.00109	0.0113	CcSEcCtD
Guanfacine—Abdominal pain—Dapsone—leprosy	0.00109	0.0113	CcSEcCtD
Guanfacine—Myocardial infarction—Thalidomide—leprosy	0.00108	0.0112	CcSEcCtD
Guanfacine—Conjunctivitis—Thalidomide—leprosy	0.00107	0.0111	CcSEcCtD
Guanfacine—Sweating—Thalidomide—leprosy	0.00106	0.011	CcSEcCtD
Guanfacine—Bradycardia—Thalidomide—leprosy	0.00101	0.0105	CcSEcCtD
Guanfacine—Rhinitis—Thalidomide—leprosy	0.000993	0.0103	CcSEcCtD
Guanfacine—Visual impairment—Thalidomide—leprosy	0.000954	0.00989	CcSEcCtD
Guanfacine—Eye disorder—Thalidomide—leprosy	0.000926	0.00959	CcSEcCtD
Guanfacine—Tinnitus—Thalidomide—leprosy	0.000923	0.00957	CcSEcCtD
Guanfacine—Immune system disorder—Thalidomide—leprosy	0.000895	0.00927	CcSEcCtD
Guanfacine—Alopecia—Thalidomide—leprosy	0.000875	0.00907	CcSEcCtD
Guanfacine—Vomiting—Dapsone—leprosy	0.000874	0.00906	CcSEcCtD
Guanfacine—Headache—Dapsone—leprosy	0.000861	0.00893	CcSEcCtD
Guanfacine—Tension—Thalidomide—leprosy	0.000846	0.00877	CcSEcCtD
Guanfacine—Dysgeusia—Thalidomide—leprosy	0.000844	0.00875	CcSEcCtD
Guanfacine—Nervousness—Thalidomide—leprosy	0.000837	0.00868	CcSEcCtD
Guanfacine—Muscle spasms—Thalidomide—leprosy	0.000829	0.00859	CcSEcCtD
Guanfacine—Nausea—Dapsone—leprosy	0.000816	0.00846	CcSEcCtD
Guanfacine—Vision blurred—Thalidomide—leprosy	0.000813	0.00842	CcSEcCtD
Guanfacine—Tremor—Thalidomide—leprosy	0.000808	0.00837	CcSEcCtD
Guanfacine—Ill-defined disorder—Thalidomide—leprosy	0.0008	0.00829	CcSEcCtD
Guanfacine—Agitation—Thalidomide—leprosy	0.000792	0.00821	CcSEcCtD
Guanfacine—Malaise—Thalidomide—leprosy	0.000778	0.00806	CcSEcCtD
Guanfacine—Vertigo—Thalidomide—leprosy	0.000775	0.00803	CcSEcCtD
Guanfacine—Syncope—Thalidomide—leprosy	0.000773	0.00801	CcSEcCtD
Guanfacine—Palpitations—Thalidomide—leprosy	0.000762	0.0079	CcSEcCtD
Guanfacine—Loss of consciousness—Thalidomide—leprosy	0.000758	0.00785	CcSEcCtD
Guanfacine—Convulsion—Thalidomide—leprosy	0.000747	0.00774	CcSEcCtD
Guanfacine—Hypertension—Thalidomide—leprosy	0.000744	0.00772	CcSEcCtD
Guanfacine—Arthralgia—Thalidomide—leprosy	0.000734	0.00761	CcSEcCtD
Guanfacine—Chest pain—Thalidomide—leprosy	0.000734	0.00761	CcSEcCtD
Guanfacine—Myalgia—Thalidomide—leprosy	0.000734	0.00761	CcSEcCtD
Guanfacine—Anxiety—Thalidomide—leprosy	0.000731	0.00758	CcSEcCtD
Guanfacine—Discomfort—Thalidomide—leprosy	0.000725	0.00752	CcSEcCtD
Guanfacine—Dry mouth—Thalidomide—leprosy	0.000718	0.00744	CcSEcCtD
Guanfacine—Confusional state—Thalidomide—leprosy	0.00071	0.00735	CcSEcCtD
Guanfacine—Oedema—Thalidomide—leprosy	0.000704	0.00729	CcSEcCtD
Guanfacine—Shock—Thalidomide—leprosy	0.000692	0.00718	CcSEcCtD
Guanfacine—Tachycardia—Thalidomide—leprosy	0.000687	0.00712	CcSEcCtD
Guanfacine—Hyperhidrosis—Thalidomide—leprosy	0.00068	0.00705	CcSEcCtD
Guanfacine—Hypotension—Thalidomide—leprosy	0.000658	0.00682	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Thalidomide—leprosy	0.000641	0.00664	CcSEcCtD
Guanfacine—Insomnia—Thalidomide—leprosy	0.000636	0.0066	CcSEcCtD
Guanfacine—Paraesthesia—Thalidomide—leprosy	0.000632	0.00655	CcSEcCtD
Guanfacine—Dyspnoea—Thalidomide—leprosy	0.000627	0.0065	CcSEcCtD
Guanfacine—Somnolence—Thalidomide—leprosy	0.000626	0.00648	CcSEcCtD
Guanfacine—Dyspepsia—Thalidomide—leprosy	0.000619	0.00642	CcSEcCtD
Guanfacine—Decreased appetite—Thalidomide—leprosy	0.000612	0.00634	CcSEcCtD
Guanfacine—Fatigue—Thalidomide—leprosy	0.000607	0.00629	CcSEcCtD
Guanfacine—Constipation—Thalidomide—leprosy	0.000602	0.00624	CcSEcCtD
Guanfacine—Feeling abnormal—Thalidomide—leprosy	0.00058	0.00601	CcSEcCtD
Guanfacine—Gastrointestinal pain—Thalidomide—leprosy	0.000575	0.00596	CcSEcCtD
Guanfacine—Abdominal pain—Thalidomide—leprosy	0.000556	0.00577	CcSEcCtD
Guanfacine—Hypersensitivity—Thalidomide—leprosy	0.000518	0.00537	CcSEcCtD
Guanfacine—Asthenia—Thalidomide—leprosy	0.000505	0.00523	CcSEcCtD
Guanfacine—Pruritus—Thalidomide—leprosy	0.000498	0.00516	CcSEcCtD
Guanfacine—Diarrhoea—Thalidomide—leprosy	0.000481	0.00499	CcSEcCtD
Guanfacine—Dizziness—Thalidomide—leprosy	0.000465	0.00482	CcSEcCtD
Guanfacine—Vomiting—Thalidomide—leprosy	0.000447	0.00464	CcSEcCtD
Guanfacine—Rash—Thalidomide—leprosy	0.000444	0.0046	CcSEcCtD
Guanfacine—Dermatitis—Thalidomide—leprosy	0.000443	0.00459	CcSEcCtD
Guanfacine—Headache—Thalidomide—leprosy	0.000441	0.00457	CcSEcCtD
Guanfacine—Nausea—Thalidomide—leprosy	0.000418	0.00433	CcSEcCtD
